Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ischemic Heart Disease in Male With Prostate Adenocarcinoma: Clinical and Pathogenetic Aspects of Diagnostics, Prognosis and Treatment

NCT03474835 is registered in ClinicalTrials.gov with Dnipropetrovsk State Medical Academy as lead sponsor.

NCT NCT03474835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03474835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ischemic Heart Disease in Male With Prostate Adenocarcinoma: Clinical and Pathogenetic Aspects of Diagnostics, Prognosis and Treatment
Lead sponsor
Dnipropetrovsk State Medical Academy
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2018
Completion date
January 15, 2019
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease, prostate adenocarcinoma